Clinical Trial Update: DP-VPA for Migraine Prophylaxis, a Pilot Efficacy Study [Phase 2]

View source ↗

Summary

A Phase 2 pilot efficacy trial evaluating DP-VPA for migraine prophylaxis was withdrawn from the clinical trials registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• DP-VPA

Snippet

Sponsor: D-Pharm Ltd. | Conditions: Migraine | Phase 2 | Status: WITHDRAWN